Respiratory distress often results in emboli or shunting,
which can be detected in cerebral blood flow.
COVID-19 is a complex disease that can affect multiple organ systems including the brain, heart, and lungs.
Patients with severe COVID-19 pneumonia display high levels of vascular shunting, which is correlated with low lung compliance. ¹
The NovaGuide Intelligent Ultrasound detected microbubbles in 83% of mechanically ventilated patients, signaling vascular shunting. ¹
The robotic nature of NovaGuide enables autonomous monitoring and reduces contact between providers and patients with COVID-19.
HPS is characterized by abnormalities in blood oxygenation caused by intrapulmonary vascular dilations. HPS has negative impacts on quality of life and survival – a diagnosis of HPS can impact status on liver transplant waiting lists.
Up to 32% of patients with severe liver disease can experience hypoxemia due to HPS. ²
The underlying causes of hypoxemia can be investigated using NovaGuide to perform a contrast enhanced bubble study. ²
NovaGuide can detect vascular shunting at the bedside in as little as 10 minutes.
ECMO is a form of cardiopulmonary life-support where blood is circulated outside the body and infused with oxygen before being recirculated back into the body.
Intracerebral hemorrhage or infarction occurs in approximately 10-15% of ARDS patients on ECMO. ³
43% of ECMO deaths are due to intracerebral hemorrhage. ³
The automated NovaGuide can be used to assess cerebral blood flow velocity for extended periods of time while a patient is receiving ECMO support.
